Review of the Series “Disease of the Year 2011: Toxoplasmosis” Pathophysiology of Toxoplasmosis

REFERENCES

• Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30:1217–1258.
   PubMed Web of Science ®Google Scholar
• Woods AC, Jacobs L, Wood RM. A study of the role of toxoplasmosis in adult chorioretinitis. Am J Ophthalmol. 1954;37:163–177.
   PubMed Web of Science ®Google Scholar
• McCannel CA, Holland GN, Helm CJ, Cornell PJ, Winston JV, Rimmer TG. Causes of uveitis in the general practice of ophthalmology. UCLA Community-Based Uveitis Study Group. Am J Ophthalmol. 1996;121:35–46.
   PubMed Web of Science ®Google Scholar
• Subauste CS, Montoya JG, Remington JS. 2008. AIDS-associated toxoplasmosis. In: Volberding, PA, Sande, MA, Greene, WC, Lange, JMA. (Eds.), Global HIV/AIDS Medicine. 399–413. Philadelphia, PA: Saunders Elsevier.
   Google Scholar
• Mets MB, Holfels E, Boyer KM, et al. Eye manifestations of congenital toxoplasmosis. Am J Ophthalmol. 1997;123:1–16.
   PubMed Web of Science ®Google Scholar
• Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992;114:136–144.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Stanford MR. Is ocular toxoplasmosis caused by prenatal or postnatal infection? B. J Ophthalmol. 2000;84:224–226.
   Web of Science ®Google Scholar
• Friedmann CT, Knox DL. Variations in recurrent active toxoplasmic retinochoroiditis. Arch Ophthalmol. 1969;81:481–493.
   PubMedGoogle Scholar
• Pavesio CE, Lightman S. Toxoplasma gondii and ocular toxoplasmosis: pathogenesis. Br J Ophthalmol. 1996;80:1099–1107.
   PubMed Web of Science ®Google Scholar
• Holland GN. Ocular toxoplasmosis: a global reassessment, part I: epidemiology and course of disease. Am J Ophthalmol. 2003;136:973–988.
   PubMed Web of Science ®Google Scholar
• Zimmerman LE. Ocular pathology of toxoplasmosis. Surv Ophthalmol. 1961;6:832–838.
   Google Scholar
• Norose K, Mun H-S, Aosai F, et al. IFN-γ-regulated Toxoplasma gondii distribution and load in the murine eye. Invest Ophthalmol Vis Sci,. 2003;44:4375–4381.
   PubMed Web of Science ®Google Scholar
• Lambert H, Hitziger N, Dellacasa I, Svensson M, Barragan A. Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell Microbiol. 2006;8:1611–1623.
   PubMed Web of Science ®Google Scholar
• Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gatel D, Tardieux I. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood. 2006;107:309–316.
   Google Scholar
• Smith JR, Franc DT, Carter NS, Zamora D, Planck SR, Rosenbaum JT. Susceptibility of retinal vascular endothelium to infection with Toxoplasma gondii tachyzoites. Invest Ophthalmol Vis Sci,. 2004;45:1157–1161.
   PubMed Web of Science ®Google Scholar
• Meenken C, Rothova A, de Waal LP, van der Horst AR, Mesman BJ, Kijlstra A. HLA typing in congenital toxoplasmosis. Br J Ophthalmol. 1995;79:494–497.
   PubMed Web of Science ®Google Scholar
• Jamieson SE, de Roubaix L-A, Cortina-Borja M, et alGenetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. Plos One. 2008;3:e2285.
   Web of Science ®Google Scholar
• Jamieson SE, Peixoto-Rangel AL, Hargrave AC, et alEvidence for associations between the purinergic receptor P2X7 (P2RX7) and toxoplasmosis. Genes Immun. 2010;11:374–383.
   PubMed Web of Science ®Google Scholar
• Cordeiro CA, Moreira PR, Andrade MS, et al. Interleukin–10 gene polymorphism (–1082G/A) is associated with toxoplasmic retinochoroiditis. Invest Ophthalmol. Vis. Sci,. 2008;49:1979–1982.
   PubMed Web of Science ®Google Scholar
• Albuquerque MC, Aleixo AL, Benchimol EI, et al. The IFN–gamma +874T/A gene polymorphism is associated with retinochoroiditis toxoplasmosis susceptibility. Mem Inst Oswaldo Cruz. 2009;104:451–455.
   PubMed Web of Science ®Google Scholar
• Yamamoto JH, Vallochi AL, Silveira C, et al. Discrimination between patients with acquired toxoplasmosis and congenital toxoplasmosis on the basis of the immune response to parasite antigens. J Infect Dis. 2000;181:2018–2022.
   PubMed Web of Science ®Google Scholar
• Ayanru JO. The problem of uveitis in Bendel State of Nigeria: experience in Benin City. Br J Ophthalmol. 1977;61:655–659.
   PubMed Web of Science ®Google Scholar
• Ronday MJ, Stilma JS, Barbe RF, et al. Aetiology of uveitis in Sierra Leone, West Africa. Br J Ophthalmol. 1996;80:956–961.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Freeman K, Lago EG, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008;2:e277.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Stanford MR, Jackson H, Holliman RE, Sanders MD. Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth. BMJ. 1995;310:1037–1040.
   PubMedGoogle Scholar
• de la Torre A, Gonzales G, Diaz–Ramirez J, Gomez–Marin JE. Screening by ophthalmoscopy for toxoplasma retinochoroiditis in Colombia. Am J Ophthalmol. 2007;143:354–356.
   PubMed Web of Science ®Google Scholar
• Ajzenberg D, Cogne N, Paris L, et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis. 2002;186:684–689.
   PubMed Web of Science ®Google Scholar
• Halos L, Thebault A, Aubert D, et al. An innovative survey underlining the significant level of contamination by Toxoplasma gondii of ovine meat consumed in France. Int J Parasitol. 2010;40:193–200.
   PubMed Web of Science ®Google Scholar
• Ajzenberg D, Yera H, Marty P, et al. Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings. J Infect Dis. 2009;199:1155–1167.
   PubMed Web of Science ®Google Scholar
• [30]Elbez–Rubinstein A, Ajzenberg D, Darde ML, et al. Congenital toxoplasmosis and reinfection during pregnancy: case report, strain characterization, experimental model of reinfection and review. J Infect Dis. 2009;199:280–285.
   PubMed Web of Science ®Google Scholar
• Howe DK, Sibley LD. Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotypes with human disease. J Infect Dis. 1995;172:1561–1566.
   PubMed Web of Science ®Google Scholar
• Dubey JP, Quirk T, Pitt JA, et al. Isolation and genetic characterization of Toxoplasma gondii from racoons (Procyon lotor), cats (Felis domesticus), striped skunk (Mephitis mephitis), black bear (Ursus americanus), and cougar (Puma concolor). from Canada. J Parasitol. 2008;94:42–45.
   PubMed Web of Science ®Google Scholar
• Dubey JP, Sundar N, Hill D, et al. High prevalence and abundant atypical genotypes of Toxoplasma gondii isolated from lambs destined for human consumption in the USA. Int J Parasitol. 2008;38:999–1006.
   PubMed Web of Science ®Google Scholar
• Ajzenberg D, Banuls AL, Su C, et al. Genetic diversity, clonality and sexuality in Toxoplasma gondii. Int J Parasitol. 2004;34:1185–1196.
   PubMedGoogle Scholar
• Khan A, Fux B, Su C, et al. Recent transcontinental sweep of Toxoplasma gondii driven by a single monomorphic chromosome. Proc Natl Acad Sci USA. 2007;104:14872–14877.
   PubMed Web of Science ®Google Scholar
• Pena HF, Gennari SM, Dubey JP, Su C. Population structure and mosue–virulence of Toxoplasma gondii in Brazil. Int J Parasitol. 2008;38:561–569.
   PubMed Web of Science ®Google Scholar
• Velmurugan GV, Dubey JP, Su C. Genotyping studies of Toxoplasma gondii isolates from Africa revealed that the archetypal clonal lineages predominate as in North America and Europe. Vet Parasitol. 2008;155:314–318.
   PubMed Web of Science ®Google Scholar
• Mercier A, Devillard S, Ngoubangoye B, et al. Additional haplogroups of Toxoplasma gondii out of Africa: population structure and mosue virulence of strains from Gabon. PLoS Negl Trop Dis. 2010;4:e876.
   Web of Science ®Google Scholar
• Neves ES, Bicudo LN, Curi AL, et al. Acute acquired toxoplasmosis: clinical–laboratorial aspects and ophthalmologic evaluation in a cohort of immunocompetent patients. Mem Inst Oswaldo Cruz. 2009;104:393–396.
   PubMed Web of Science ®Google Scholar
• Carme B, Demar M, Ajzenberg D, Darde ML. Severe acquired toxoplasmosis caused by wild cycle of Toxoplasma gondii, French Guiana. Emerg Infect Dis. 2009;15:656–658.
   PubMed Web of Science ®Google Scholar
• Delhaes L, Ajzenberg D, Sicot B, et al. Severe congenital toxoplasmosis due to a Toxoplasma gondii strain with an atypical genotype: case report and review. Prenat Diagn. 2010;30:902–905.
   PubMed Web of Science ®Google Scholar
• Bowie WR, King AS, Werker DH, et al. Outbreak of toxoplasmosis associated with municipal drinking water: The BC Toxoplasma Investigation Team. Lancet. 1997;350:173–177.
   PubMed Web of Science ®Google Scholar
• Vallochi AL, Muccioli C, Martins MC, Silveira C, Belfort RJ, Rizzo LV. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am J Ophthalmol. 2005;139:350–351.
   PubMed Web of Science ®Google Scholar
• Khan A, Jordan C, Muccioli C, et al. Genetic divergence of Toxoplasma gondii strains associated with ocular toxoplasmosis, Brazil. Emerg. Infect Dis. 2006;12:942–949.
   PubMed Web of Science ®Google Scholar
• Fekkar A, Ajzenberg D, B. B, et al. Direct genotyping of Toxoplasma gondii in ocular fluid samples from 20 patients with ocular toxoplasmosis: predominance of type II in France. J Clin Microbiol. 2011: Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Grigg ME, Ganatra J, Boothroyd JC. T.P.M. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. J Infect Dis. 2001;184:633–639.
   PubMed Web of Science ®Google Scholar
• Silveira C, Vallochi AL, Rodrigues da Silva U, et al. Toxoplasma gondii in the peripheral blood of patients with acute and chronic toxoplasmosis. Br J Ophthalmol. 2010: Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Switaj K, Master A, Borkowski PK, Skrzypczak M, Wojciechowicz J, Zaborowski P. Association of ocular toxoplasmosis with type I Toxoplasma gondii strains: direct genotyping from peripheral blood samples. J Clin Microbiol. 2006;44:4262–4264.
   PubMed Web of Science ®Google Scholar
• Nowakowska D, Colon I, Remington JS, et al. Genotyping of Toxoplasma gondii by multiplex PCR and peptide–based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis. J Clin Microbiol. 2006;44:1382–1389.
   PubMed Web of Science ®Google Scholar
• Morisset S, Peyron F, Lobry JR, et al. Serotyping of Toxoplasma gondii: striking homogeneous pattern between symptomatic and asymptomatic infections within Europe and South America. Microbes Infect. 2008;10:742–747.
   PubMed Web of Science ®Google Scholar
• Hu MS, Schwartzman JD, Lepage AC, Khan IA, Kasper LH. Experimental ocular toxoplasmosis induced in naive and preinfected mice by intracameral inoculation. Ocul Immunol Inflamm. 1999;7:17–26.
   PubMed Web of Science ®Google Scholar
• Hu MS, Schwartzman JD, Yeaman GR, et al. Fas–FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice. Infect Immun. 1999;67:928–935.
   PubMed Web of Science ®Google Scholar
• Lu F, Huang S, Kasper LH. CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis. Infect Immun. 2004;72:4966–4972.
   PubMed Web of Science ®Google Scholar
• Charles E, Callegan MC, Blander IJ. The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice. Infect Immun. 2007;75:2079–2083.
   PubMed Web of Science ®Google Scholar
• Tedesco RC, Smith RL, Corte–Real S, Calabrese KS. Ocular toxoplasmosis in mice: comparison of two routes of infection. Parasitology. 2005;131:303–307.
   PubMed Web of Science ®Google Scholar
• McMenamin PG, Dutton GN, Hay J, S.C, . The ultrastructural pathology of congenital murine toxoplasmic retinochoroiditis, part I: The localization and morphology of Toxoplasma cysts in the retina. Ex. Eye Res. 1986;43:529–543.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Orellana MA, Schreiber RD, Remington JS. Interferon–γ: the major mediator of resistance against Toxoplasma gondii. Science. 1988;240:516–518.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Conley FK, Remington JS. Importance of endogenous IFN–γ for prevention of toxoplasmic encephalitis in mice. J Immunol. 1989;143:2045–2050.
   PubMed Web of Science ®Google Scholar
• Gazzinelli RT, Wysocka M, Hayashi S, et al. Parasite–induced IL–12 stimulates early IFN–γ synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol. 1994;153:2533–2543.
   PubMed Web of Science ®Google Scholar
• Yap G, Pesin M, Sher A. IL–12 is required for the maintenance of IFN–γ production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. J Immunol. 2000;165:628–631.
   PubMed Web of Science ®Google Scholar
• Gazzinelli RT, Brezin A, Li Q, Nussenblatt RB, Chan CC. Toxoplasma gondii: acquired ocular toxoplasmosis in the murine model, protective role of TNF–α and IFN–γ. Exp Parasitol. 1994;78:217–229.
   PubMed Web of Science ®Google Scholar
• Norose K, Aosai F, Mizota A, Yamamoto S, Mun H–,S Yano, A. Deterioration of visual function as examined by electroretinograms in Toxoplasma gondii–infected IFN–γ–knockout mice. Invest Ophthalmol Vis. Sci,. 2005;46:317–321.
   PubMedGoogle Scholar
• Lassoued S, Zabraniecki L, Marin F, Billey T. Toxoplasmic chorioretinitis and antitumor necrosis factor treatment in rheumatoid arthritis. Semin Arthritis Rheum. 2007;36:262–263.
   PubMed Web of Science ®Google Scholar
• Roberts F, Roberts CW, Ferguson DJP, McLeod R. Inhibition of nitric oxide production exacerbates chronic ocular toxoplasmosis. Parasite Immunol. 2000;22:1–5.
   Google Scholar
• Portillo J–,AC Okenka, G, Reed E, et al. The CD40–autophagy pathway is needed for host protection despite IFN–γ–dependent immunity and CD40 induces autophagy via control of p21 levels. Plos One. 2010;e14472.
   Google Scholar
• Shen DF, Mattheson DM, Tuaillon N, Suedekum BK, Buggage RR, Chan C–C,. Involvement of apoptosis and interferon–γ in murine toxoplasmosis. Invest Ophthalmol Vis Sci,. 2001;42:2031–2036.
   PubMed Web of Science ®Google Scholar
• Hayashi S, Chan C–C,Gazzinelli, RT, Pham NTH, Cheung MK, Roberge FG. Protective role of nitric oxide in ocular toxoplasmosis. Br J Ophthalmol. 1996;80:644–648.
   PubMed Web of Science ®Google Scholar
• Naginemi CN, Pardhasaradhi K, Martins MC, Detrick B, Hooks JJ. Mechanisms of interferon–induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells. Infect Immun. 1996;64:4188–4196.
   PubMed Web of Science ®Google Scholar
• Lyons RE, Anthony JP, Ferguson DJP, Alexander J, Roberts F, Roberts CW. Immunological studies of chronic ocular toxoplasmosis: up–regulation of major histocompatibility complex class I and transforming growth factor β and a protective role for interleukin–6. Infect Immun. 2001;69:2589–2595.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Yang Q, Conley FK, Abrams JS, Remington JS. Antibody against interleikin–6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis. Infect Immun. 1994;62:2773–2778.
   PubMed Web of Science ®Google Scholar
• Jebbari H, Roberts CW, Ferguson DJP, Bluethmann H, Alexander J. A protective role for IL–6 during early infection with Toxoplasma gondii. Parasite Immunol. 1998;20:231–239.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Remington JS. Dual regulation of resistance against Toxoplasma gondii infection by Lyt–2+ and Lyt–1+, L3T4+ T cells in mice. J Immunol. 1988;140:3943–3946.
   PubMed Web of Science ®Google Scholar
• Gazzinelli R, Xu Y, Hieny S, Cheever A, Sher A. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. J Immunol. 1992;149:175–180.
   PubMed Web of Science ®Google Scholar
• Norose K, Kikumura A, Luster AD, Hunter CA, Harris TH. CXCL10 is required to maintain T cell populations and control parasite replication during chronic ocular toxoplasmosis. Invest Ophthalmol Vis Sci,. 2010; Epub ahead of print.
   Web of Science ®Google Scholar
• Subauste CS, Koniaris AH, Remington JS. Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii–infected cells. J Immunol. 1991;147:3955–3959.
   PubMed Web of Science ®Google Scholar
• Montoya JG, Lowe KE, Clayberger C, et al. Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii–infected cells. Infect Immun. 1996;64:176–181.
   PubMed Web of Science ®Google Scholar
• Denkers EY, Yap G, Scharton–Kersten T, et al. Perforin–mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. J Immunol. 1997;159:1903–1908.
   PubMed Web of Science ®Google Scholar
• Brown CR, McLeod R. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. J Immunol. 1990;145:3438–3441.
   PubMed Web of Science ®Google Scholar
• Lu F, Huang S, Hu MS, Kasper LH. Experimental ocular toxoplasmosis in genetically susceptible and resistant mice. Infect Immun. 2005;73:5160–5165.
   PubMed Web of Science ®Google Scholar
• van Kooten C, Banchereau J. CD40–CD40 ligand. J Leuk Biol. 2000;67:2–17.
   PubMed Web of Science ®Google Scholar
• Subauste CS. Primary immunodeficiencies and susceptibility to parasitic infections. Parasite Immunol. 2006;28:567–575.
   PubMed Web of Science ®Google Scholar
• Reichmann G, Walker W, Villegas EN, et al. The CD40/CD40 ligand interaction is required for resistance to toxoplasmic encephalitis. Infect Immun. 2000;68:1312–1318.
   PubMed Web of Science ®Google Scholar
• Andrade RM, Wessendarp M, Gubbels MJ, Striepen B, Subauste CS. CD40 induces macrophage anti–Toxoplasma gondii activity by triggering autophagy–dependent fusion of pathogen–containing vacuoles and lysosomes. J Clin Invest. 2006;116:2366–2377.
   PubMed Web of Science ®Google Scholar
• Subauste CS. Autophagy and immunity against Toxoplasma gondii. Curr Topics Microbiol Immunol. 2009;335:251–265.
   PubMed Web of Science ®Google Scholar
• Liesenfeld O, Kosek J, Remington JS, Suzuki Y. Association of CD4+ T cell–dependent, interferon–γ–mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J Exp Med. 1996;184:597–607.
   PubMed Web of Science ®Google Scholar
• Gazzinelli RT, Wysocka M, Hieny S, et al. In the absence of endogenous IL–10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL–12, IFN–γ, and TNF–α. J Immunol. 1996;157:798–805.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Sher A, Yap G, et al. IL–10 is required for prevention of necrosis in the small intestine and mortality in both genetically resistant BALB/c and susceptible C57BL/6 mice following peroral infection with Toxoplasma gondii. J Immunol. 2000;164:5375–5382.
   PubMed Web of Science ®Google Scholar
• Wilson EH, Wille–Reece U, Dzierszinski F, Hunter CA. A critical role for IL–10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol. 2005;165:63–74.
   PubMed Web of Science ®Google Scholar
• Lu F, Huang S, Kasper LH. Interleukin–10 and pathogenesis of murine ocular toxoplasmosis. Infect Immun. 2003;71:7159–7163.
   PubMed Web of Science ®Google Scholar
• Charles E, Joshi S, Ash JD, et al. CD4 T–cell suppression by cells from Toxoplasma gondii–infected retinas is mediated by surface protein PD–L1. Infect Immun. 2010;78:3484–3492.
   PubMed Web of Science ®Google Scholar
• Stein–Streilein J. Immure regulation and the eye. Trends Immunol. 29:548–554.
   Google Scholar
• Nagineni CN, Detrick B, Hooks JJ. Transforming growth factor–β expression in human retinal pigmented epithelial cells is enhanced by Toxoplasma gondii: a possible role in the immunopathogenesis of retinochoroiditis. Clin Exp Immunol. 2002;128:372–378.
   PubMed Web of Science ®Google Scholar
• Jones LA, Alexander J, Roberts CW. Ocular toxoplasmosis: in the storm of the eye. Parasite Immunol. 2006;28:635–642.
   PubMed Web of Science ®Google Scholar
• Ohta K, Yamagami S, Taylor AW, Streilein JW. IL–6 antagonizes TGF–beta and abolishes immune privilege in eyes with endotoxin–induced uveitis. Invest Ophthalmol Vis Sci,. 2000;41:2591–2599.
   PubMed Web of Science ®Google Scholar
• Tedesco RC, Smith RL, Corte–Real S, Calabrese KS. Ocular toxoplasmosis: the role of retinal pigment epithelium migration in infection. Parasitol Res. 2004;92:467–472.
   PubMed Web of Science ®Google Scholar
• Naginemi CN, Detrick B, Hooks JJ. Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL–1), IL–6, granulocyte–macrophage ceolony–stimulating factor, and intercellular adhesion molecule 1 by human retinal epithelial cells. Infect Immun. 2000;68:407–410.
   PubMed Web of Science ®Google Scholar
• Kang H, Remington JS, Suzuki Y. Decreased resistance of B cell–deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN–γ, TNF–α, and inducible nitric oxide synthase. J Immunol. 2000;164:2629–2643.
   PubMed Web of Science ®Google Scholar
• Stumhofer JS, Laurence A, Wilson EH, et al. Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol. 2006;7:937–945.
   PubMed Web of Science ®Google Scholar
• Munoz M, Heimesaat MM, Danker K, et al. Interleukin (IL)–23 mediates Toxoplasma gondii–induced immunopathology in the gut via matrixmetalloproteinase–2 and IL–22 but independent of IL–17. J Exp Med. 2009;206:3047–3059.
   PubMed Web of Science ®Google Scholar
• Guiton R, Vasseur V, Charron S, et al. Interleukin 17 receptor signaling is deleterious during Toxoplasma gondii infection in susceptible BL6 mice. J Infect Dis. 2010;202:427–435.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Mittal KK, Fuhrman S, Sharma SD, Palestine AG. Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens. Am J Ophthalmol. 1989;107:632–641.
   PubMed Web of Science ®Google Scholar
• Kijlstra A, Hoekzema R, vd Lelij A, Doekes G, Rothova A. Humoral and cellular immune reactions against retinal antigens in clinical disease. Curr Eye Res. 1990;9 Suppl.:85–89.
   PubMedGoogle Scholar
• Feron EJ, Klaren VN, Wierenga EA, Verjans GM, Kijlstra A. Characterization of Toxoplasma gondii–specific T cells recovered from vitreous fluid of patients with ocular toxoplasmosis. Invest Ophthalmol Vis Sci, 2001;42:3228–3232.
   PubMed Web of Science ®Google Scholar
• Desmonts G. Definitive serological diagnosis of ocular toxoplasmosis. Arch Ophthalmol. 1966;76:839–851.
   PubMedGoogle Scholar
• Kijlstra A, Breebaart AC, Baarsma GS, et al. Aqueous chamber taps in toxoplasmic chorioretinitis. Doc Ophthalmol. 1986;64:53–58.
   PubMed Web of Science ®Google Scholar
• de Boer JH, Verhagen C, Bruinenberg M, et al. Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol. 1996;121:650–658.
   PubMed Web of Science ®Google Scholar
• Klaren VN, van Doornik CE, Ongkosuwito JV, Feron EJ, Kijlstra A. Differences between intraocular and serum antibody responses in patients with ocular toxoplasmosis. Am J Ophthalmol. 1998;126:698–706.
   PubMed Web of Science ®Google Scholar
• Ongkosuwito JV, Feron EJ, van Doornik CE, et al. Analysis of immunoregulatory cytokines in ocular fluid samples from patients with uveitis. Invest Ophthalmol Vis Sci. 1998;39:2659–2665.
   PubMed Web of Science ®Google Scholar
• Lahmar I, Abou–Bacar A, Abdelrahman T, et al. Cytokine profiles in toxoplasmic and viral uveitis. J Infect Dis. 2009;199:1239–1249.
   PubMed Web of Science ®Google Scholar